8DV

(R)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1H-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine

Created:	2017-01-26
Last modified:	2020-06-05

Find Related PDB Entry
1 entries where 8DV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	1
Bond Count	62
Aromatic Bond Count	16

2D diagram of 8DV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(R)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1H-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine
Synonyms	4-{4-[1-(cyclopropylsulfonyl)cyclopropyl]-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-2-yl}-1H-indole
Systematic Name (OpenEye OEToolkits)	(3~{R})-4-[6-(1-cyclopropylsulfonylcyclopropyl)-2-(1~{H}-indol-4-yl)pyrimidin-4-yl]-3-methyl-morpholine
Formula	C₂₃ H₂₆ N₄ O₃ S
Molecular Weight	438.543
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1(C)COCCN1c6cc(C3(S(=O)(=O)C2CC2)CC3)nc(c4c5c(ccc4)ncc5)n6
SMILES	CACTVS	3.385	C[CH]1COCCN1c2cc(nc(n2)c3cccc4[nH]ccc34)C5(CC5)[S](=O)(=O)C6CC6
SMILES	OpenEye OEToolkits	2.0.6	CC1COCCN1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C6CC6
Canonical SMILES	CACTVS	3.385	C[C@@H]1COCCN1c2cc(nc(n2)c3cccc4[nH]ccc34)C5(CC5)[S](=O)(=O)C6CC6
Canonical SMILES	OpenEye OEToolkits	2.0.6	C[C@@H]1COCCN1c2cc(nc(n2)c3cccc4c3cc[nH]4)C5(CC5)S(=O)(=O)C6CC6
InChI	InChI	1.03	InChI=1S/C23H26N4O3S/c1-15-14-30-12-11-27(15)21-13-20(23(8-9-23)31(28,29)16-5-6-16)25-22(26-21)18-3-2-4-19-17(18)7-10-24-19/h2-4,7,10,13,15-16,24H,5-6,8-9,11-12,14H2,1H3/t15-/m1/s1
InChIKey	InChI	1.03	NTJNSGIJAQGTSK-OAHLLOKOSA-N

Related Resource References

Resource Name	Reference
PubChem	46244706

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.